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Introduction
The most serious illnesses of salivary glands are
tumors, that occur usually in major salivary glands
(80-85%) [1]. The most frequent are benign glandular
epithelium tumors, i.e. adenoma polymorphum, ade-
nolymphoma [2]. Salivary gland neoplasms are not
responsive to radiation, thus surgery is the therapeutic
method of choice [3].
The monitoring of the patients after salivary gland
tumors surgery is an important clinical issue. The pos-
sibility of recurrence after incomplete tumor excision
is likely. Still imperfect diagnostic procedures also
remain a challenge for searching new sensitive and
specific biomarkers of neoplastic processes in salivary
glands [4,7].
The development of tumors can cause a change in
activity and structure of enzymes. The alteration in
enzymatic activity can occur due to both increased
biosynthesis, expulsion to the blood and the presence
of necrotic or inflamed foci. Destruction of surround-
ing tissue is caused by lysosomal exoglycosidases.
Exoglycosidases catabolize glycoconjugates (glyco-
proteins, proteoglycans, glycolipids). Lysosomal exo-
glycosidases act on the external nonreducing part of
oligosaccharide chain of glycoconjugates, thus starting
the chain reaction, where the product of the previous
reaction becomes a substrate for the next one. The exo-
glycosidases degrade, in consequence, glycoproteins,
proteoglycans, glycolipids that form the cellular mem-
brane and intercellular matrix. Among exoglycosidas-
es there are: N-acetyl-β-hexosoaminidase (HEX), β-
glucuronidase (GLU), β-galactosidase (GAL), α-man-
nosidase (MAN) and α-fucosidase (FUC) [9-13].
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in salivary glands. The aim of the presented study was an the assessment of the activity of HEX, with its isoforms HEX-A
and HEX-B, GLU, GAL, MAN and FUC in salivary gland tumor tissues in comparison to a healthy salivary gland tissues
taken during autopsy. A group of 42 patients with benign and malignant salivary gland tumors, aged 25-65 were examined.
Fragments of salivary gland tumor tissue, fragments of healthy tissue removed during autopsy, blood serum and saliva were
collected from patients with salivary gland tumors and healthy volunteers. In salivary gland tumor tissue the activity of
HEX, HEX-A, HEX-B, GAL, FUC was considerably higher than in comparison to healthy salivary gland tissue and ascend-
ing trend of activity of GLU, MAN was also noticed. The activity of all lysosomal exoglycosidases in blood serum in
patients with salivary gland tumors was considerably higher in comparison to healthy volunteers blood serum. The consid-
erably higher activity of HEX, HEX-A, GLU, GAL, MAN, FUC and descending trend of activity of HEX-B were noticed
in saliva of patients with salivary gland tumors in comparison to healthy volunteers. The assessment of HEX in blood serum
and saliva of patients with salivary gland tumor can be possibly used in diagnostics and monitoring of salivary glands
tumors.
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The aim of the presented study was an the assess-
ment of the activity of HEX, with its isoforms HEX-A
and HEX-B, GLU, GAL, MAN and FUC in salivary
gland tumor tissues in comparison to a healthy salivary
gland tissues taken during autopsy. Moreover the activ-
ity of studied glycosidases was assessed in blood serum
and saliva taken from patients with salivary gland
tumors and in blood serum of healthy volunteers.
Materials and methods
Patients. The 42 patients with benign and malignant tumors of
salivary glands, in age between 25 and 65, both of sex, not smok-
ing, without concomitant disease, operated in Department of Max-
illo-Facial Surgery Medical University in Bialystok and Otolaryn-
gology Department of Provincial Hospital in Bialystok were exam-
ined. Autopsy material was derived from Forensic Medicine
Department of Medical University in Bialystok. 
Salivary gland tissue and saliva. Fragments of salivary gland
tumor tissue were collected after the surgical removal of tumor
mass. Fragments of healthy tissue were collected from subjects
deceased due to non-neoplastic causes during autopsy before 12
hours after death - all the subjects died as a result of sudden death.
Saliva samples were taken from patients with salivary gland
tumors and healthy volunteers. The taken tissues were immediate-
ly frozen in liquid nitrogen and subsequently stored in -80°C until
further analysis. After thawing the tissues were homogenized and
centrifuged for 20 min. at 12 000 × g. Biochemical analyses were
performed in collected supernatant. Collected saliva samples were
homogenized and stored in -80°C until further analysis.
Blood. The blood samples were taken from patients with salivary
gland tumors and healthy individuals in hospital conditions, in fast-
ing state, in volume of 5 ml for clot. The samples were centrifuged
for 10 min at 3500 × g and obtained serum was stored in -80°C
until further analysis.
Enzymes activity. The activities of lysosomal exoglycosidases
were estimated by method of Chatterjee et al in Zwierz et al mod-
ification [12].
Ethical issues. Research protocol was approved by Bioethics
Committee of Medical University in Bialystok (protocol number
R-I003/332/2005 i R-I-002/32/2007).
Statistical analysis. Obtained results were tested for normal distri-
bution using Kolomogrov-Smirnov test. For variables with normal
distribution independent two-sample t-test was used. For variables
with non-normal distribution U-Mann-Whitney test was used. The
test were perfomred using Statistica ver. 6.0 (StatSoft, Tulsa, Okla-
homa, USA). Statistical significance was considered if p<0.05.
Results
Detailed results of exoglycosidases activity measure-
ments are presented in Tables 1 and 2.
Table 1. Statistical analysis of hexosoaminidase (HEX) and its isoforms (HEX-A and HEX-B) activity (expressed in μKat/mg of protein)
in patients with salivary gland tumors in comparison to healthy subjects. All variables have normal distribution.
Table 2. Statistical analysis of β-glucuronidase (GLU), β-galactosidase (GAL), α-mannosidase (MAN) and β-fucosidase (FUC) activity
(expressed in μKat/mg of protein) in patients with salivary gland tumors in comparison to healthy subjects. All variables have normal dis-
tribution.
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In salivary gland tumor tissue the activity of lyso-
somal exoglycosidases, expressed as nKat/mg of pro-
tein amounted respectively HEX: 7.7±2.72 nKat/mg,
HEX-A: 5.4±2.02 nKat/mg, HEX-B: 2.3±0.91
nKat/mg, GLU: 0.6±0.19 nKat/mg, GAL: 0.3±0.11
nKat/mg, MAN: 0.22±0.77 nKat/mg, FUC: 0.22±0.09
nKat/mg (Fig. 1).
In saliva collected from patients with salivary
gland tumors the activity of HEX, HEX-A, HEX-B,
GLU, GAL, MAN, FUC amounted respectively:
1.1±0.29 nKat/mg, 0.8±0.26 nKat/mg, 0.1±0.06
nKat/mg, 0.04±0.01 nKat/mg, 0.0018±0.001
nKat/mg, 0.015±0.006 nKat/mg, 0.005±0.003
nKat/mg (Fig. 2).
In blood serum collected from patients with sali-
vary gland tumors the activity of HEX, HEX-A, HEX-
B, GLU, GAL, MAN, FUC amounted respectively
140.5±22.87 nKat/mg, 98.0±19.51 nKat/mg,
42.5±12.22 nKat/mg, 38.3±11.2 nKat/mg, 16.7±5.71
nKat/mg, 19.6±7.99 nKat/mg, 24.0±6.92 nKat/mg
(Fig. 3).
In salivary gland tumor tissue the activity of HEX,
HEX-A, HEX-B, GAL, FUC was considerably lower
in comparison to healthy salivary gland tissue, as well
as activity of GLU, MAN and FUC. 
Fig. 1. The activity of lysosomal exoglycosidases: (A) HEX and
HEX-A and HEX-B isoenzymes and (B) GLU, GAL, MAN, FUC
in resected salivary gland tumor tissue in comparison to healthy
tissue obtained during autopsy.
Fig. 2. The activity of lysosomal exoglycosidases: (A) HEX and
HEX-A and HEX-B isoenzymes and (B) GLU, GAL, MAN, FUC
in saliva of patients with salivary gland tumors in comparison to
healthy individuals.
Fig. 3. The activity of lysosomal exoglycosidases: (A) HEX and
HEX-A and HEX-B isoenzymes and (B) GLU, GAL, MAN, FUC
in serum of patients with salivary gland tumors in comparison to
healthy individuals.
Significantly lower activity of HEX, HEX-A, HEX-
B, GLU and MAN were noticed in saliva of patients
with salivary gland tumors in comparison to healthy
volunteers. The activity of GLU in saliva was signifi-
cantly higher in patients with salivary gland tumors.
The activity of all lysosomal exoglycosidases in
blood serum in patients with salivary gland tumors was
considerably higher in comparison to healthy volun-
teers blood serum.
Discussion
Glycoconjugates undergo constant metabolism con-
cerned with degradation of old and synthesis of new
particles. Degradation of glycoconjugates in lyso-
somes is performed by lysosomal exoglycosidases
HEX, HEX-A, HEX-B, GLU, GAL, MAN and FUC. 
The intensification of catabolism, typical for neoplas-
tic process, expressed by elevated activity of lysosomal
exoglycosidases in tumor comparing to healthy tissue,
represent a differential factor. The elevated activity of
lysosomal exoglycosidases in the blood and saliva can
be of diagnostic and prognostic importance [1-4].
Above statement can be the cause for further inves-
tigation, whether the difference in lysosomal activity
of exoglycosidases can be used in diagnostics and
monitoring of salivary glands tumors. 
The activity of lysosomal exoglycosidases was
confirmed in every examined material (salivary gland
tumor tissue, healthy salivary gland tissue, blood
serum and saliva). HEX was the most active lysosomal
exoglycosidase in tissue of salivary gland tumor, blood
serum and saliva of patients with tumor [12,13].
Tumors of salivary glands and associated inflamma-
tion increase biosynthesis and movement of lysosomal
exoglycosidases from tumor tissue to blood and saliva.
The assessment of lysosomal exoglycosidases in tissue
of salivary gland tumor has a great cognitive and cer-
tain diagnostic value [14]. Our studies are one of few
attempts to assess the usability of exoglycosidases
activity measurements for diagnosis of salivary glands
tumors. The assessment of HEX in blood serum and
saliva of patients with salivary gland tumor can be pos-
sibly used in diagnostics and monitoring of salivary
glands tumors.
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